drugset / Trial / NCT06476834
A Study Evaluating Deucravacitinib Concentrations in the Breast Milk and Plasma of Healthy Lactating Female Participants
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate Deucravacitinib concentrations in the breast milk and plasma of healthy lactating female participants.
Timeline
- Start
- 2024-06-24
- Primary completion
- 2024-11-02
- Completion
- 2024-11-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CRAVACITINIB | Small molecule | — | — |
Indications
No indication recorded.